We serve Chemical Name:[1-(1H-Indol-3-yl)ethyl]amine CAS:19955-83-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:[1-(1H-Indol-3-yl)ethyl]amine
CAS.NO:19955-83-0
Synonyms:1-(1H-indol-3-yl)ethanaMine
Molecular Formula:C10H12N2
Molecular Weight:160.21600
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:41.81000
Exact Mass:160.10000
LogP:2.88790
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-(1H-indol-3-yl)ethanaMine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(1H-indol-3-yl)ethanaMine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(1H-indol-3-yl)ethanaMine Use and application,1-(1H-indol-3-yl)ethanaMine technical grade,usp/ep/jp grade.
Related News: Compared to white women, Black women are more likely to be diagnosed with breast cancer before age 50 or with estrogen receptor (ER)-negative and triple-negative breast cancer. [1-(1H-Indol-3-yl)ethyl]amine manufacturer Compared to white women, Black women are more likely to be diagnosed with breast cancer before age 50 or with estrogen receptor (ER)-negative and triple-negative breast cancer. [1-(1H-Indol-3-yl)ethyl]amine supplier It’s a disturbing set of events, scientifically, clinically, politically, Karlawish said. [1-(1H-Indol-3-yl)ethyl]amine vendor Retrogenix holds two Queen��s Awards for Enterprise, the UK��s most prestigious acknowledgement of business performance. The company is headquartered near Manchester, UK, and has an office in Cambridge, MA. [1-(1H-Indol-3-yl)ethyl]amine factory Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis.